Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 26, Iss 3, Pp 444-467 (2020)
Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by presence of the BCR-ABL fusion gene which encodes the constitutively active BCR-ABL chimeric protein. Imatinib is first FDA approved first-line BCR-ABL targeting drug fo
Externí odkaz:
https://doaj.org/article/0a9e8e008fac48f89dadfc7412cab09d